These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 22605933)
1. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933 [TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers. Gokce EH; Korkmaz E; Tuncay-Tanrıverdi S; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():5109-17. PubMed ID: 23055723 [TBL] [Abstract][Full Text] [Related]
3. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Neves AR; Lúcio M; Martins S; Lima JL; Reis S Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193 [TBL] [Abstract][Full Text] [Related]
4. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells. Barbosa JP; Neves AR; Silva AM; Barbosa MA; Reis MS; Santos SG Int J Nanomedicine; 2016; 11():3501-16. PubMed ID: 27555771 [TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112 [TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M Daru; 2011; 19(1):23-32. PubMed ID: 22615636 [TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications. Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056 [TBL] [Abstract][Full Text] [Related]
10. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Teskac K; Kristl J Int J Pharm; 2010 May; 390(1):61-9. PubMed ID: 19833178 [TBL] [Abstract][Full Text] [Related]
12. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456 [TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations. Jain S; Addan R; Kushwah V; Harde H; Mahajan RR Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706 [TBL] [Abstract][Full Text] [Related]
14. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. Shrotriya SN; Ranpise NS; Vidhate BV Drug Deliv Transl Res; 2017 Feb; 7(1):37-52. PubMed ID: 27981502 [TBL] [Abstract][Full Text] [Related]
15. Development, Statistical Optimization, and Characterization of Resveratrol-Containing Solid Lipid Nanoparticles (SLNs) and Determination of the Efficacy in Reducing Neurodegenerative Symptoms Related to Alzheimer's Disease: In Vitro and In Vivo Study. Khishvand MA; Yeganeh EM; Zarei M; Soleimani M; Mohammadi M; Mahjub R Biomed Res Int; 2024; 2024():7877265. PubMed ID: 39376256 [TBL] [Abstract][Full Text] [Related]
16. A comparative study on the possible cytotoxic effects of different nanostructured lipid carrier (NLC) compositions in human dermal fibroblasts. Brugè F; Damiani E; Marcheggiani F; Offerta A; Puglia C; Tiano L Int J Pharm; 2015 Nov; 495(2):879-85. PubMed ID: 26392245 [TBL] [Abstract][Full Text] [Related]
17. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. Ruktanonchai U; Bejrapha P; Sakulkhu U; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S AAPS PharmSciTech; 2009; 10(1):227-34. PubMed ID: 19280350 [TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. Pathak P; Nagarsenker M AAPS PharmSciTech; 2009; 10(3):985-92. PubMed ID: 19641997 [TBL] [Abstract][Full Text] [Related]